|1.||Pietsch, Hubertus: 1 article (12/2014)|
|2.||Lenhard, Diana C: 1 article (12/2014)|
|3.||May, Ekkehard: 1 article (12/2014)|
|4.||Morgenroth, Christine: 1 article (12/2014)|
|5.||Jost, Gregor: 1 article (12/2014)|
|6.||Haider, Wolfram: 1 article (12/2014)|
|7.||Mizuno, Ju: 1 article (01/2007)|
|8.||Arita, Hideko: 1 article (01/2007)|
|9.||Hanaoka, Kazuo: 1 article (01/2007)|
|10.||Suzuki, Masahiro: 1 article (01/2007)|
07/01/1991 - "There was a significant difference (p = 0.04) between the two groups with respect to delayed pain, when iotrolan was associated with a lower incidence and decreased severity of delayed pain. "
10/01/1989 - "Iotrolan and ioxaglate caused equal postprocedural pain (in about 50% of patients). "
01/01/1989 - "However, one patient reported slight pain after the injection of iotrolan even when no previous injection of iopromide had been performed; (2) in intravenous DSA contrast appeared 1 to 2 seconds later in the region of interest after the injection of iotrolan compared with iopromide, probably due to the slightly higher viscosity of the former agent; (3) otherwise, no differences between the two agents have been observed. "
01/01/1989 - "Despite problems in the interpretation of results due to a "hangover" effect in selective peripheral arteriography, it may be concluded: (1) Iotrolan causes significantly less discomfort, such as the feeling of heat and most likely also pain, than iopromide. "
01/01/1989 - "Side effects were limited to transient local erythema and pain during the infusion in one patient and a protracted reaction resembling serum sickness in another patient (Iotrolan 240 mg I/ml). "
05/01/1995 - "Iotrolan induced generalized seizures in 5 rabbits, iodixanol 320 mg I/ml in 2 rabbits, and iodixanol 150 mg I/ml in one rabbit. "
11/01/1983 - "Metrizamide induced the fewest seizures, but, considering the slow waves and the seizures, iotrol appears to be the least neurotoxic."
11/01/1995 - "Iotrolan produced generalised grand mal seizures in 8/10 rabbits, an incidence of excitation significantly greater than that of iodixanol (p < 0.01) and iopamidol (p < 0.05). "
|3.||Body Weight (Weight, Body)
01/01/1989 - "In this study iotrolan showed excellent tolerance after intravenous injection up to 0.9 g I/kg body weight."
01/01/1989 - "In a double-blind comparative study between the nonionic, dimeric iotrolan and the nonionic, monomeric iopromide the urographic image quality in the dose 300 mg I/kg body weight is better after iopromide up to 20 minutes after the injection. "
11/01/1999 - "The effects of RCM (diatrizoate 370 mgI ml-1, ioxaglate 320 mgI ml-1, iotrolan 300 mgI ml-1 and iopromide 300 mgI ml-1) at a dose of 4 ml kg-1 body weight or control solutions matched for volume, pH and osmolarity administered via the jugular vein on Raw were studied. "
01/01/2003 - "The experiments were repeated in rabbits using CT imaging and iopromide or iotrolan plus urea (52 mg/mL) or iloprost (20 ng/mL) and iodine doses of 50 mg/kg body weight. "
12/01/2014 - "After intravenous injection of iopromide (monomeric), iodixanol (dimeric), and iotrolan (dimeric) at a dose of 4 g iodine/kg of body weight, mechanical ear volume measurements (10 minute after injection) and intravital microscopy (baseline, 5 minutes after injection) of the ear with the near-infrared dye indocyanine green were performed to determine the volume change and plasma extravasation. "
|4.||Abdominal Pain (Pain, Abdominal)
|4.||Diatrizoate Meglumine (Gastrograffin)
|8.||Ioxaglic Acid (Ioxaglate Meglumine)
|9.||Ethiodized Oil (Ethiodol)
|2.||Artificial Respiration (Mechanical Ventilation)